A5320: Viral Hepatitis C Infection Long-term Cohort Study

  • Question: Observational long-term follow-up study in hepatitis C monoinfected and HCV/HIV-1 coinfected subjects.
  • Population: Men and women who received DAA therapy for HCV as part of a clinical trial within the last 12 months. HCV monoinfected or HCV/HIV-1 coinfected. SVR or non-SVR.
  • Medication: No medication is provided. If participant is non-SVR, they may undergo repeat treatment on another clinical trial or through standard of care while enrolled in A5320
  • Duration: Q6 month visits for 5 years
  • Contact: Erin Hoffman 919-843-0720

Status: On-going / Recruiting


  • Question: Online, interactive self-management program for HIV+ young men accompanied by weekly anonymous online support group
  • Population: Born male, currently identify as male, have had sex with a man in their lifetime, 16-24 years old – inclusive, have consistent access to the internet
  • Medication: No medication is provided
  • Duration: One initial visit for enrollment. Six week intervention period with weekly online support group
  • Contact: Helene Kirchke-Schwartz, 919-843-4722

Test Rehearsal:

  • Question: Virtual reality program used by people to practice and familiarize themselves with at-home HIV testing
  • Population: Born male, HIV- or status unknown, have sex with men or intend to, 14-19 years old, English-speaking
  • Medication: No medication is provided
  • Duration: One hour-long session
  • Contact: Kelly Knudtson, 919-962-4640

Enlaces por la Salud:

  • Question: A linkage, engagement, and education program for Mexican males and Mexican transgender females in North Carolina. Bilingual personal health navigators work one-on-one with clients to deliver a 6-session culturally tailored curriculum with the goal of encouraging and improving HIV health self-management
  • Population: Born male, Mexican or Mexican-American, newly diagnosed within the past six months OR previously diagnosed more than 6 months ago from baseline and not engaged/inconsistently engaged in care.
  • Medication: No medication is provided
  • Duration: Six month intervention period, with follow up until 18 months after enrollment
  • Contact: Joaquín Carcano,